Grant and Funding Programs Offered by The Shohet Family Fund for Ewing Sarcoma Research

The Shohet Family Fund is a designated Hero Fund within St. Baldrick's Foundation, one of the largest non-government funders of childhood cancer research in the world. The fund was established in memory of Noah Shohet, who was diagnosed with Ewing sarcoma at age 19 and passed away in 2021 at age 25. The family raises money to advance Ewing sarcoma research and find cures for this rare bone cancer that affects approximately 200 adolescents and young adults annually in the United States.

Donations to the Shohet Family Fund have directly funded multiple research grants, including: St. Baldrick's Fellow grant for Dr. Christopher Kuo at Children's Hospital Los Angeles (2023-2026), St. Baldrick's Scholar grant for Dr. David Libich at University of Texas Health Science Center San Antonio (2019-2023), and Research Grants for Dr. Joseph Ludwig at MD Anderson Cancer Center (2018-2019 and 2022-2023). The fund also partnered with the ACES (Advancing Cures for Ewing Sarcoma) initiative, contributing $300,000 over three years to support Dr. Brian Ladle's immunotherapy research at Johns Hopkins University toward a Phase 1 clinical trial.

As part of St. Baldrick's Foundation, the Shohet Family Fund benefits from a rigorous peer-review process involving over 180 pediatric oncology experts. St. Baldrick's has awarded more than $371 million across 1,968 grants to 384 institutions in 32 countries. The foundation is guided by a Scientific Advisory Committee to ensure every dollar makes the greatest impact for children with cancer.